Skip to main content
OXFORD NANOPORE TECHNOLOGIES PLC logo

OXFORD NANOPORE TECHNOLOGIES PLC — Investor Relations & Filings

Ticker · ONT ISIN · GB00BP6S8Z30 LEI · 213800IRWQ2Q6M2CDW55 IL Manufacturing
Open in API
Filings indexed 370 across all filing types
Latest filing 2025-02-03 Declaration of Voting R…
Country GB United Kingdom
Listing IL ONT

About OXFORD NANOPORE TECHNOLOGIES PLC

https://nanoporetech.com/

Oxford Nanopore Technologies PLC develops and commercializes a proprietary technology platform for DNA and RNA sequencing. The company's core technology is based on nanopore sensing, which enables the direct, real-time analysis of single molecules. This electronic method facilitates the sequencing of native nucleic acids, generating long-read data without requiring amplification. The platform is uniquely scalable, offering a range of products from portable, pocket-sized devices like the MinION to high-throughput instruments for population-scale projects. This technology provides researchers with immediate access to data, enabling rapid insights across various fields of biological research, including human genetics, cancer research, microbiology, and environmental science.

Recent filings

Filing Released Lang Actions
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement disseminated via RNS (Regulatory News Service), indicated by the RNS Number and the closing statement referencing the London Stock Exchange and FCA. The content explicitly details the 'Issue of Equity' (issuance of 298,194 ordinary shares) and updates the 'Total Voting Rights' as of January 31, 2025. This directly relates to changes in the company's share capital structure and total shares outstanding, which falls under the 'Share Issue/Capital Change' definition (SHA). Although it mentions RNS distribution, the core subject matter is the capital change, making SHA more specific than the general RPA or RNS fallback.
2025-02-03 English
SIP PDMR Notification and Correction
Remuneration Information Classification · 99% confidence The document is an official notification released via RNS (RNS Number: 1171T) concerning transactions by a Person Discharging Managerial Responsibilities (PDMR), specifically Nick Keher (CFO/Director). It details the purchase and grant of shares under a Share Incentive Plan (SIP) and includes a correction to a previous notification. This type of filing, which reports personal share transactions by directors/executives, directly corresponds to the definition of Director's Dealing (DIRS). The reference to Article 19(3) of the UK Market Abuse Regulation confirms its regulatory nature regarding insider transactions.
2025-01-13 English
Full Year Trading Update and Notice of Results
Earnings Release Classification · 100% confidence The document is titled 'Full Year Trading Update and Notice of Results' and provides preliminary financial highlights (revenue, gross margin) for the twelve months ended 31 December 2024 (FY24), which is an annual period. It explicitly states that the company will announce its 'preliminary annual results' on a future date (4 March 2025). This structure—a pre-announcement of annual performance metrics ahead of the formal results release—is characteristic of an Earnings Release (ER) or a preliminary trading update. Since it covers the full year and provides detailed performance metrics, it is more substantial than a simple 'Notice of Dividend' or 'Capital Update'. However, it is not the comprehensive Annual Report (10-K) itself, nor is it a transcript or a formal audit report. Given the content focuses on summarizing the full year's financial performance ahead of the official results, 'Earnings Release' (ER) is the most appropriate classification for this type of pre-results trading update, even though it covers a full year, as it serves the function of an early earnings disclosure. FY 2024
2025-01-13 English
Presentation at 43rd Annual J.P. Morgan Conference
Regulatory Filings Classification · 98% confidence The document is an RNS announcement (RNS Number : 2898S) dated January 7, 2025. The content explicitly states that Oxford Nanopore Technologies plc will 'Present at 43rd Annual J.P. Morgan Healthcare Conference' and provides details about the CEO's presentation time and a link to a webcast. This is an announcement about participation in an external industry event, not the release of a formal statutory report (like 10-K, IR, or ER). Since it is a general regulatory announcement distributed via RNS that doesn't fit the specific categories like DIV, DIRS, or CAP, the most appropriate classification is the general regulatory filing category, RNS, as it serves as a notification to the market about corporate activity.
2025-01-07 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 3000S' and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a 'TR-1: Standard form for notification of major holdings' regarding an acquisition of voting rights by EIT Oxford Holdings, LLC, crossing a threshold. This type of mandatory disclosure regarding significant changes in share ownership falls directly under the category of Major Shareholding Notification (MRQ). Although RNS is present, MRQ is a more specific classification for this content type than the general RNS fallback.
2025-01-06 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the 'Issue of Equity' (issuance of 125,356 ordinary shares) following option exercises and remuneration schemes, and subsequently announces the 'Total Voting Rights' as of December 31, 2024. This type of mandatory disclosure regarding changes in the total number of shares and voting rights, often triggered by share issuance or repurchase, fits best under the category dealing with capital structure changes or general regulatory announcements. Since it specifically reports on the issuance of new shares and the resulting total share count, it strongly aligns with 'Share Issue/Capital Change' (SHA). However, given the context of RNS being the source and the nature of the announcement being a routine update on share capital changes required by the FCA, SHA is the most precise fit over the general RNS fallback.
2025-01-02 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.